ArticleCarcinogenesis2016

Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.

Anup Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.